Sarmal, Inc.

👥 6 employees💰 Last funded Aug 2021
Biotechnology Research🌐 sarmal.com
Website LinkedIn
Sarmal, Inc. is a genomics company developing next generation innovations in sequencing and advanced target sequence detection FLASH Sequencing A single molecule, DNA sequencing technology that, for the first time, can achieve unlimited read lengths. This technology transforms the the field of genomics by achieving whole genome sequencing with a cost of well under $100 dollars per genome using low-cost devices, and game-changing low error rates. DeTaiL Platform A portable, field deployable nucleic acid based diagnostic platform, that will that achieve cost-effective gold-standard specificity and sensitivity in five minutes - sample-to-answer. This makes possible the profound goal of screening large population a reality.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Turkey
2
Frequently asked questions
Who invested in Sarmal, Inc.?
Sarmal, Inc. has 2 investors on record on gritt.io.
When did Sarmal, Inc. last raise funding?
The most recent investment in Sarmal, Inc. recorded on gritt.io was in August 2021.
What industry is Sarmal, Inc. in?
Sarmal, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.